Pfizer As of June 21, 2022 ticker dps (an.) 2022 hike 2021 hike 2020 hike
PFE $1.60 0.0% 2.6% 2.6%
Business yield Hike yrs 5 yr CAGR freq. paid since
Pharmaceuticals 3.3% 12 4.6% Quarter 1938
Pfizer has now raised its dividend 11 straight years © logo Pfizer Inc.
Pfizer has now raised its dividend 11 straight years © logo Pfizer Inc.

Global biopharmaceutical company Pfizer (PFE) will raise its quarterly dividend by 2.6 percent to 39 cents per share quarterly. This follows a 5.6 percent dividendhike to $0.38 per share announced in the first quarter of 2020. This marks the 11th consecutive year of dividend increases by PFE.

The next dividend is payable March 5, 2021 to holders of the Common Stock of record at the close of business on January 29, 2021. A new annual dividend rate of $1.56 per share yields 4.1% at a stock price of $37.68. The first-quarter 2021 cash dividend will be the 329th consecutive quarterly dividend paid by Pfizer.

The transaction to combine Upjohn with Mylan to form Viatris Inc. closed on November 16, 2020. It is expected that Viatris will begin paying a quarterly dividend in the second quarter of 2021, at which time Pfizer’s quarterly dividend will be reduced such that the combined dividend dollar amount received by Pfizer shareholders, based upon the combination of continued Pfizer ownership and approximately 0.124079 shares of Viatris which were granted for each Pfizer share in the spin-off, will equate to Pfizer’s dividend amount in effect immediately prior to the initiation of the Viatris dividend.

“Our commitment to returning capital to shareholders is strong and the dividend increase reflects our continued confidence in the business and in our scientific pipeline,” stated Dr. Albert Bourla, Pfizer Chairman and CEO. “It also reinforces that our focus on creating meaningful value for patients benefits all our stakeholders.”

Pfizer Inc. is a biopharmaceutical company with a global portfolio that includes medicines, vaccines and consumer healthcare products. The company runs its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The majority of Pfizer's revenues come from the manufacture and sale of biopharmaceutical products. The company's brands include Advil, Centrum, Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra. Pfizer was incorporated in 1942 and had its IPO in 1944.

Dividend Calendar

Look at the complete list of upcoming events
Ex-date Ticker Yield YTD hike
Jul 05 CSCO 3.4% 2.7%
Jul 05 CMCSA 2.8% 8.0%
Jul 05 DGX 2.0% 6.5%
Jul 05 GPS 6.8% 25.0%
Jul 05 JPM 3.5% 0.0%
Jul 06 CPB 3.1% 0.0%
Jul 06 SRE 3.2% 4.1%
Jul 07 ROP 0.6% 0.0%
Jul 07 MA 0.6% 0.0%
Jul 07 NTAP 3.1% 0.0%